Evidence map›Paper›PMID 39486797›Full record

ArticleBMJ open gastroenterology2024

Exploring the feasibility of home-delivered capsule endoscopy with 5G support: innovations and carbon footprint insights.

Gohar Jalayeri Nia, Cassie Conway, Frances Ward, Sheena Dungey, Linda Streames, Bei Bei Liu, Ian Lo Lei, James Cameron, Hagen Wenzek, Chander Shekhar and 2 more

Abstract read
In one paragraph

Article in BMJ open gastroenterology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gohar Jalayeri NiaUniversity Hospital Coventry & Warwickshire NHS Trust, Coventry, UK doctornia@yahoo.com.ORCID 0009-0004-8668-899X
Cassie ConwayArden and GEM Commissioning Support Unit, Coventry, UK.
Frances WardArden and GEM Commissioning Support Unit, Coventry, UK.
Sheena DungeyArden and GEM Commissioning Support Unit, Coventry, UK.
Linda StreamesCorporateHealth International, Odense, Denmark.
Bei Bei LiuUniversity Hospital Coventry & Warwickshire NHS Trust, Coventry, UK.
Ian Lo LeiUniversity Hospital Coventry & Warwickshire NHS Trust, Coventry, UK.
James CameronCorporateHealth International, Odense, Denmark.
Hagen WenzekCorporateHealth International, Odense, Denmark.
Chander ShekharUniversity Hospital Coventry & Warwickshire NHS Trust, Coventry, UK.
Sally EasonArden and GEM Commissioning Support Unit, Coventry, UK.
Ramesh P ArasaradnamUniversity of Warwick and University of Coventry, Coventry, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionColorectal cancer (CRC) poses a significant global health threat, necessitating early detection. Traditional diagnostic tools like optical colonoscopy have limitations prompting our '5G-SUCCEEDS' initiative to explore a novel approach involving remote colon capsule endoscopy (CCE).

methodsThis prospective feasibility study was conducted at a single hospital in England. Between December 2022 and September 2023, we introduced a remote CCE service within the 5G-SUCCEEDS framework. We undertook a feasibility study of CCE in patients with low-risk/moderate-risk CRC stratified by faecal haemoglobin. Outcomes included carbon footprint analysis (outlined through three potential clinical pathways) and patient-reported outcomes through structured questionnaires and interviews.

resultsAmong 25 participants, 88% expressed satisfaction with remote CCE. 82% were willing to have remote CCE if clinically indicated in future. CCE findings included adenomatous polyps (58%), normal results (17%) and diverticulosis (21%), with no cancers identified in this pilot. Notably, we found that the carbon footprint associated with delivery of CCE at home (pathway 3) was lower compared with CCE delivered in a clinical setting (pathway 2). A fully optimised, automated scaled-up pathway would combine the delivery and collection of CCE equipment within a local area to reduce the carbon footprint of the travel element by 75%. Moreover, the conversion rate into a colonoscopy pathway is not static and clinicians acknowledge that this could be as low as 28%. Carbon footprint is more favourable for home-delivered CCE in the optimised scenario, while less so when considering the need for additional procedures (colonoscopy conversion).

conclusionThe 5G-SUCCEEDS initiative highlights the feasibility and advantages of home-based diagnostics using CCE.

Indexed as

Capsule EndoscopyCarbon FootprintColorectal NeoplasmsEarly Detection of CancerFeasibility StudiesAgedColonoscopyEnglandFemaleHumansMaleMiddle AgedPatient SatisfactionProspective StudiesSurveys and QuestionnairesTelemedicinecolonoscopycolorectal cancerendoscopy

Identifiers

PMID39486797
PMCPMC11529455

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.